Complications, Mortality, and Costs for Outpatient and Short-Stay Total Knee Arthroplasty Patients in Comparison to Standard-Stay Patients
Section snippets
Methodology
The Medicare 5% Limited Data Set (LDS) sample was used to identify patients with a total knee arthroplasty procedure between 1997 and 2009 using ICD-9-CM (81.54) and CPT4 (27447) codes. Patients were recruited continuously during the study period and followed until the end of the study period (December 31, 2009), until their benefits were terminated, or until death. Patients who received benefits for a reason other than age (i.e., end-stage renal disease or disability) and Medicare
Results
There were 71,341 3–4 day standard-stay patients, 23,134 5 + day, 7755 1–2 day, and 454 outpatient patients in the study cohort. Outpatient and 1–2 day stay patients tended to be younger and with a lower Charlson comorbidity score (Fig. 1, Fig. 2). Compared to the 3–4 day standard-stay group, the incremental payments for osteoarthritis attributable costs at 2 years were −$8527 (lower) for the outpatient group, −$1967 (lower) for the 1–2 day group, and +$1159 (higher) for the 5 + day group (Fig. 3).
Discussion
We estimated the costs, mortality and complications after TKA for differing lengths of stay in the U.S. Medicare population. Compared to standard-stay patients, there were sizeable cost reductions but an increased revision/readmission and mortality risk for the outpatient and short stay TKA groups. The shorter stay groups showed an improvement in associated diagnosed pain and stiffness compared to standard-stay patients, suggesting better early function. Patients who stayed, or were obliged to
References (14)
- et al.
Relationship between length of stay and manipulation rate after total knee arthroplasty
J Arthroplasty
(1998) - et al.
Does shortened length of hospital stay affect total knee arthroplasty rehabilitation outcomes?
J Arthroplasty
(2005) - et al.
Accelerated rehabilitation after total knee replacement
Knee
(2005) - et al.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
J Chronic Dis
(1987) - et al.
Adverse events after total knee arthroplasty: a national Medicare study
J Arthroplasty
(2009) - et al.
Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030
J Bone Joint Surg Am
(2007) - et al.
A comprehensive joint replacement program for total knee arthroplasty: a descriptive study
BMC Musculoskelet Disord
(2008)
Cited by (235)
The Utility of the Social Vulnerability Index as a Proxy for Social Disparities Following Total Knee Arthroplasty
2024, Journal of ArthroplastySleep Apnea is Not an Obstacle for Outpatient Hip and Knee Arthroplasty
2024, Journal of Arthroplasty
Study design, manuscript preparation, and review occurred at the offices of each author independently. The initial study design and data processing took place at Exponent, Inc., in Philadelphia, PA and Menlo Park, CA. All statistical analyses took place at Exponent, Inc., in Menlo Park, CA.
Support for this research was provided by Stryker.
The Conflict of Interest statement associated with this article can be found at http://dx.doi.org/10.1016/j.arth.2013.07.020.